Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Adagrasib

Pneumonitis, cardiac failure and pulmonary haemorrhage

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Gadgeel S, et al. MA06.04 KRYSTAL-1: Two-Year Follow-Up of Adagrasib (MRTX849) Monotherapy in Patients with Advanced/Metastatic KRASG12C-Mutated NSCLC. Journal of Thoracic Oncology 18 (Suppl.): S118, No. 11, Nov 2023. Available from: URL: https://dx.doi.org/10.1016/j.jtho.2023.09.152 [abstract] Gadgeel S, et al. MA06.04 KRYSTAL-1: Two-Year Follow-Up of Adagrasib (MRTX849) Monotherapy in Patients with Advanced/Metastatic KRASG12C-Mutated NSCLC. Journal of Thoracic Oncology 18 (Suppl.): S118, No. 11, Nov 2023. Available from: URL: https://dx.doi.org/10.1016/j.jtho.2023.09.152 [abstract]
Metadaten
Titel
Adagrasib
Pneumonitis, cardiac failure and pulmonary haemorrhage
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-50249-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Dulaglutide

Case report

Golimumab

Case report

Multiple drugs

Case report

Imatinib

Case report

Multiple drugs